A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study
- PMID: 2599466
- DOI: 10.1016/0090-8258(89)90070-x
A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study
Abstract
Thirty-three institutions collaborating in the Gynecologic Oncology Group gathered surgical and pathological data on 1125 patients with primary, previously untreated, histologically confirmed stage I cervical carcinoma with more than 3 mm of invasion who were selected to undergo radical hysterectomy and paraaortic and pelvic lymphadenectomy. Of the 940 eligible, evaluable patients, 732 had squamous carcinoma. Of the study group, 87 (12%) did not undergo radical hysterectomy because of gross disease beyond the uterus or microscopic aortic node involvement documented at exploratory laparotomy. Among the 645 patients undergoing pelvic and paraaortic lymphadenectomy and radical hysterectomy, five risk factors were significantly associated with microscopic pelvic lymph node metastasis: depth of invasion (P = 0.0001), parametrial involvement (P = 0.0001), capillary-lymphatic space invasion (P = 0.0001), tumor grade (P = 0.01), and gross versus occult primary tumor (P = 0.009). The factors identified as independent risk factors for pelvic lymph node metastasis by multivariate analysis were capillary-lymphatic space involvement (P less than 0.0001), depth of invasion (P less than 0.0001), parametrial involvement (P = 0.0005), and age (P = 0.02). The model was used to predict the chance of a patient having nodal metastasis for any combination of risk factors.
Similar articles
-
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.Gynecol Oncol. 1996 Dec;63(3):304-11. doi: 10.1006/gyno.1996.0327. Gynecol Oncol. 1996. PMID: 8946863 Clinical Trial.
-
Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51. doi: 10.1034/j.1600-0412.2002.811208.x. Acta Obstet Gynecol Scand. 2002. PMID: 12519111
-
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.Gynecol Oncol. 1990 Sep;38(3):352-7. doi: 10.1016/0090-8258(90)90072-s. Gynecol Oncol. 1990. PMID: 2227547 Clinical Trial.
-
Microinvasive carcinoma of the cervix.Cancer. 1992 Oct 15;70(8):2121-8. doi: 10.1002/1097-0142(19921015)70:8<2121::aid-cncr2820700819>3.0.co;2-s. Cancer. 1992. PMID: 1394041 Review.
-
Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.Obstet Gynecol. 2010 Nov;116(5):1150-7. doi: 10.1097/AOG.0b013e3181f74062. Obstet Gynecol. 2010. PMID: 20966701 Review.
Cited by
-
Postoperative radiation therapy for carcinoma of the uterine cervix.Radiat Med. 2006 Feb;24(2):91-7. doi: 10.1007/BF02493274. Radiat Med. 2006. PMID: 16715669 Review.
-
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.Gynecol Oncol. 2011 Aug;122(2):275-80. doi: 10.1016/j.ygyno.2011.04.023. Epub 2011 May 13. Gynecol Oncol. 2011. PMID: 21570713 Free PMC article.
-
The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.Virchows Arch. 2018 Jul;473(1):45-54. doi: 10.1007/s00428-018-2372-7. Epub 2018 May 24. Virchows Arch. 2018. PMID: 29799071 Review.
-
Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.BMC Womens Health. 2024 Mar 19;24(1):182. doi: 10.1186/s12905-024-03001-6. BMC Womens Health. 2024. PMID: 38504245 Free PMC article.
-
Histological grading and DNA content as predictors of distant metastases in squamous cell carcinoma of the uterine cervix.Arch Gynecol Obstet. 1991;249(4):157-63. doi: 10.1007/BF02390382. Arch Gynecol Obstet. 1991. PMID: 1796828